3-morpholinobenzo[b][1,6]naphthyridine-4-carbonitrile

ID: ALA5218687

Chembl Id: CHEMBL5218687

Cas Number: 371930-20-0

PubChem CID: 913079

Max Phase: Preclinical

Molecular Formula: C17H14N4O

Molecular Weight: 290.33

Associated Items:

Names and Identifiers

Canonical SMILES:  N#Cc1c(N2CCOCC2)ncc2cc3ccccc3nc12

Standard InChI:  InChI=1S/C17H14N4O/c18-10-14-16-13(9-12-3-1-2-4-15(12)20-16)11-19-17(14)21-5-7-22-8-6-21/h1-4,9,11H,5-8H2

Standard InChI Key:  PJFPONBJUKXJGA-UHFFFAOYSA-N

Associated Targets(Human)

SK-N-AS (237 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-1080 (3966 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 290.33Molecular Weight (Monoisotopic): 290.1168AlogP: 2.49#Rotatable Bonds: 1
Polar Surface Area: 62.04Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.53CX LogP: 2.63CX LogD: 2.63
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.64Np Likeness Score: -1.40

References

1. Rank L, Puhl AC, Havener TM, Anderson E, Foil DH, Zorn KM, Monakhova N, Riabova O, Hickey AJ, Makarov V, Ekins S..  (2022)  Multiple approaches to repurposing drugs for neuroblastoma.,  73  [PMID:36208544] [10.1016/j.bmc.2022.117043]

Source